Pancreatic Cancer Research

ResearcherUniversity of FlorenceActive in the last 2 years

Tiziano Lottini

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1495-0918; OpenAlex author ID A5012093310. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

  1. Targeting the hERG1/β1 integrin complex in lipid rafts potentiates statins anti-cancer activity in pancreatic cancer. Co-author DOI 10.1038/s41420-025-02321-2↗
  2. Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers15072013↗
  3. Generation of an Orthotopic Xenograft of Pancreatic Cancer Cells by Ultrasound-Guided Injection. Co-author DOI 10.3791/63123↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Claudia Duranti · 3 shared papers, 2021–2025 · strength 0.56
  2. Annarosa Arcangeli · 3 shared papers, 2021–2025 · strength 0.56
  3. Elena Lastraioli · 1 shared paper, 2023 · strength 0.16
  4. Stefano Coppola · 1 shared paper, 2023 · strength 0.16
  5. Alessandro Coppola · 1 shared paper, 2023 · strength 0.16
  6. Vincenzo La Vaccara · 1 shared paper, 2023 · strength 0.16
  7. Roberto Coppola · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.